How will they test the effectiveness of a vaccine? And the virus can mutate just like the flu does every year...
An ebola prevention market is emerging. Demand is growing. Government action (sending troops to hot zones) and inaction (refusing to take the logical steps necessary to prevent infected people from entering the U.S., failing to properly protect health care workers and the public-at-large) is at the root of rising demand. Who stands to financially benefit from this?